Omission of Radiotherapy After Breast-Conserving Surgery for Women With Breast Cancer With Low Clinical and Genomic Risk: 5-Year Outcomes of IDEAReshma Jagsi, Mahmoud El‐Tamer, Mahvish Muzaffar et al.|Journal of Clinical Oncology|2023Cited by 100
Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohortAbdul Rafeh Naqash, Paul R. Walker, Biagio Ricciuti et al.|Cancer Immunology Immunotherapy|2020Cited by 97
Planned Interim Analysis Results from a Prospective Multicenter Single-Arm Cohort Study of Patients Receiving Endocrine Therapy but Not Radiotherapy after Breast-Conserving Surgery for Early-Stage Breast Cancer with Favorable Biologic FeaturesReshma Jagsi, Mahmoud El‐Tamer, Kent A. Griffith et al.|International Journal of Radiation Oncology*Biology*Physics|2019Cited by 6
Correction to: Outcomes associated with immune-related adverse events in metastatic non-small cell lung cancer treated with nivolumab: a pooled exploratory analysis from a global cohortAbdul Rafeh Naqash, Paul R. Walker, Biagio Ricciuti et al.|Cancer Immunology Immunotherapy|2020Cited by 3
Reply to G.B. Mann et al and S. SorscherReshma Jagsi, Mahmoud El‐Tamer, Kent A. Griffith et al.|Journal of Clinical Oncology|2024Cited by 1